about
PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal DiseaseEffects of Streptococcus pneumoniae strain background on complement resistanceEnhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis modelBeta-lactam activity against resistant pneumococcal strains is enhanced by the immune system.Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae.Inactivation of the Thymidylate Synthase thyA in Non-typeable Haemophilus influenzae Modulates Antibiotic Resistance and Has a Strong Impact on Its Interplay with the Host Airways.Nasopharyngeal colonization and invasive disease are enhanced by the cell wall hydrolases LytB and LytC of Streptococcus pneumoniae.Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae.Inspecting the potential physiological and biomedical value of 44 conserved uncharacterised proteins of Streptococcus pneumoniaeEffects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model.The effects of methionine acquisition and synthesis on Streptococcus pneumoniae growth and virulenceImportance of bacterial replication and alveolar macrophage-independent clearance mechanisms during early lung infection with Streptococcus pneumoniae.Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections.Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune ResponseMaturation of Streptococcus pneumoniae lipoproteins by a type II signal peptidase is required for ABC transporter function and full virulence.Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathwayScreening of Streptococcus pneumoniae ABC transporter mutants demonstrates that LivJHMGF, a branched-chain amino acid ABC transporter, is necessary for disease pathogenesis.Immunization with LytB protein of Streptococcus pneumoniae activates complement-mediated phagocytosis and induces protection against pneumonia and sepsis.Fluoroquinolone-resistant pneumococci: dynamics of serotypes and clones in Spain in 2012 compared with those from 2002 and 2006.Apoptosis, Toll-like, RIG-I-like and NOD-like Receptors Are Pathways Jointly Induced by Diverse Respiratory Bacterial and Viral Pathogens.DiiA is a novel dimorphic cell wall protein of Streptococcus pneumoniae involved in invasive disease.Secular trends (1990-2013) in serotypes and associated non-susceptibility of S. pneumoniae isolates causing invasive disease in the pre-/post-era of pneumococcal conjugate vaccines in Spanish regions without universal paediatric pneumococcal vaccinaBiofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae.Macrolides and β-lactam antibiotics enhance C3b deposition on the surface of multidrug-resistant Streptococcus pneumoniae strains by a LytA autolysin-dependent mechanism.Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune responseThe effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype.Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotypeCombined effect of specific antibodies (as serotherapy or preimmunization) and amoxicillin doses in treatment of Streptococcus pneumoniae sepsis in a mouse model.Impaired opsonization with complement and phagocytosis of Streptococcus pyogenes in sera from subjects with inherited C2 deficiency.Modification of bacteraemia by specific antibodies and relation with mortality in a pneumococcal mouse sepsis model.Mucin 1 is a novel glycoprotein involved in host defense against invasive pneumococcal disease.Chemotherapy with Phage Lysins Reduces Pneumococcal Colonization of the Respiratory Tract.Modulation of Haemophilus influenzae interaction with hydrophobic molecules by the VacJ/MlaA lipoprotein impacts strongly on its interplay with the airways.[Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the Pneumonia Prevention Expert Group]Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal diseaseBactericidal synergism between antibiotics and phage endolysin Cpl-711 to kill multidrug-resistant pneumococcusOverview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory TractDisposable amperometric magnetoimmunosensors for the specific detection of Streptococcus pneumoniaeImpaired C3b/iC3b deposition on Streptococcus pneumoniae in serum from patients with systemic lupus erythematosus
P50
Q27315060-13A33788-1D82-4512-B2F7-6674D8363421Q28743913-12B43594-93F5-49BD-B305-7506F0DA80C3Q28749838-1096FD84-7519-49C7-A27B-622C706BA60FQ30332446-392B2539-5A6C-4772-BEDF-134EFB211D00Q33298405-9C14E029-01BC-47BC-9EC2-E4315A01C71DQ33812986-8F6AD95C-A18C-423D-BEB7-0C9C4A4F931DQ34008872-38642416-FB78-444D-97DA-E0CD2FCE89A2Q34033151-3F034394-5F05-4BBF-9FD3-03C0990141DDQ34085006-6E798BD4-AEDB-4894-956D-1F71E6E2D395Q34106926-6EFDC614-512D-4886-A8C6-8D3023E3AD46Q34561978-A4390D45-425C-4EF2-8B6F-647F687505D3Q35098250-76442515-5125-41D6-9E70-2F2A76EA269AQ35682692-B9806898-19EC-466E-8983-8A7E8D4BA84FQ35773895-80871FBB-3328-4D4C-887C-7930D9BD58DCQ36433703-423D5B01-4CA7-488C-9F00-7828B222EC92Q36804267-223ED1F7-0BC2-4AC7-9AFB-4CFE0187A1F6Q37274808-023487DF-F4EF-4A3D-A5A1-E1CAFAA7F98AQ38795815-59C2A390-1F54-4C97-8ABB-6DF05816194BQ39682438-251B4405-EF8F-47AE-8E3F-7E5C4DC8EFEDQ40290315-F1EBF4D0-6E8C-4F85-8687-11D65EEAA130Q40702937-9591EE1C-FEB5-4B78-BEA4-9C2F6F95B194Q41014805-1135118C-3BF8-453D-B770-7AE7BAC3E305Q41432621-A32BB2EF-CC84-4191-BD39-394CBE0A49BCQ41570386-3502399E-4806-4A7A-AEAC-486D60F8AB95Q41658036-95FA0C74-EED5-4F7F-BAC8-07F97EDF5038Q41893972-74B52073-1CEC-48A9-810D-2E143C17760CQ42040636-7F8EF9F6-91E6-499F-AA78-F99AFAA476EFQ42792405-53B95307-BE17-4818-B786-F72711CAAFBAQ43934864-50A0DAA0-2488-41EE-A829-374C410076F8Q44029840-200ED5A0-9E4C-40A6-A21E-7FD76A7D1147Q53152268-EFD4D377-232D-443C-9064-2587C85FEF91Q54247935-7441DB6A-2E48-4237-88BE-CE9DA6FB1560Q55347367-A09EC341-DABF-44DD-8EA7-7BB44D43E5D2Q57477256-ACAB247C-A04B-420E-9160-92839D40166EQ58476742-66A3ABD5-1ED0-42EA-9F43-A45BE1CF5D55Q58703020-02CB0128-42C2-46F2-8CAE-436A54676639Q58765017-5A099BB4-9E25-4FF5-9236-5FDD4D7C8D64Q59791499-E5E91A35-5BA6-4648-8DCE-865739EFF6BEQ60700187-AC5AFDF5-D376-44DD-A14B-8D4C14D704E3Q84614638-9BAE48BE-3BD6-4BAF-8E0B-7B864103031C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jose Yuste
@ast
Jose Yuste
@en
Jose Yuste
@es
Jose Yuste
@nl
Jose Yuste
@sl
type
label
Jose Yuste
@ast
Jose Yuste
@en
Jose Yuste
@es
Jose Yuste
@nl
Jose Yuste
@sl
prefLabel
Jose Yuste
@ast
Jose Yuste
@en
Jose Yuste
@es
Jose Yuste
@nl
Jose Yuste
@sl
P106
P1153
7003876619
P21
P31
P496
0000-0001-7996-0837